Navigation Links
Research identifies type of vaccine that holds promise in protecting against TB
Date:10/19/2008

be even more potent than the one just studied and does not include the antibiotic resistant gene, Hoft said.

"A new vaccine theoretically could not only protect against the overwhelming growth of TB organisms, but could kill residual organisms after a person has become infected. That's the hope," Hoft said.

It's critical to find a better vaccine, Hoft said. Tuberculosis strikes developing nations hardest, infecting one in three people worldwide. Nearly 8 million new cases of TB develop each year, and 2 million die from the infectious disease.

"These staggering statistics persist despite the availability of a tuberculosis vaccine," Hoft said. "New vaccines are urgently needed to reduce this immense burden of TB."

The World Health Organization recommends the current BCG vaccine for infants in developing countries shortly after they are born. The vaccine induces partial protection, and vaccinated children who contract a tuberculosis infection have a less severe illness. The current vaccine is about 70 percent protective against deaths or meningitis from tuberculosis and about 50 percent protective against pulmonary tuberculosis.


'/>"/>

Contact: Nancy Solomon
solomonn@slu.edu
314-977-8017
Saint Louis University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers identify Achilles heel of common childhood tumor
2. Waste from gut bacteria helps host control weight, UT Southwestern researchers report
3. Salk researchers successfully reprogram keratinocytes attached to a single hair
4. Scripps research team sheds light on immune system suppression
5. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
6. MU brain imaging center provides research for autism, schizophrenia and Parkinsons disease
7. Cost-effective farm waste-to-energy technology focus of research
8. Alzheimers disease research attracts first partner
9. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
10. Researchers identify promising gene target for neuroblastoma therapy
11. Salk researcher Terry Sejnowski elected to Institute of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...team of pioneering South Korean scientists have su...y plastics through bioengineering, rather than thr...groundbreaking research, which may now allow for t...s, is published in two papers in the journal Biot...s 50th anniversary. , Polymers are molecules fo...
(Date:11/22/2009)...Cambridge, MA November 23, 2009 Agios Pharmaceut...ablished, for the first time, that the mutated IDH... a cancer-causing gene, or oncogene. This breakthr... produces a metabolite, 2-hydroxyglutarate (2HG), ...t progression of gliomas, the most common type of ...
(Date:11/20/2009)... a research report published in the November 2009 ...ics.org ), scientists show how a family of genes (... genes) are responsible for production of ethylene...nt, and this information lays the foundation for f...disease resistant, able to survive and thrive in d...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4It's a gas: New discovery may lead to heartier, high-yielding plants 2Hologic to Release Fourth Quarter and Fiscal 2009 Operating Results on Monday November 9 2009 58885 1Hologic to Release Fourth Quarter and Fiscal 2009 Operating Results on Monday November 9 2009 58885 2Hanger Orthopedic Group Inc Announces Third Quarter 2009 Earnings Release Conference Call 58881 1Hanger Orthopedic Group Inc Announces Third Quarter 2009 Earnings Release Conference Call 58881 2ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 1ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 2ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 3ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema 28MIVI II DME 29 14355 4
...s announces the latest addition to its Cumulative ... (Cumitechs) publication series: Cumitech 46 -- L... Parasitic Diseases. , This Cumitech is intended ...d other members of the patient care team in the ap...ests for the diagnosis and management of blood-bor...
...ch team has developed the first small molecule tha...n balancing sodium levels, paving the way for drug...nditions. , The human epithelial sodium channel ...ch as the lungs, kidneys, and colon, and it is vit...essure. Interestingly, while there are available d...
...born in India and Sri Lanka are three times more l...n pregnancy (hyperemesis gravidarum) than ethnic N...nstitute of Public Healths study of 900, 000 first...Registry of Norway over a forty year period. , E...t women experience some degree of nausea and vomit...
Other Biology News:Extreme nausea and vomiting varies among pregnant women from different countries 2
(Date:11/20/2009)...Newswire/ -- Veridiam (www.veridiam.com) won the p...ategory at the 2009 Workplace Excellence Awards. T...or Human Resources Management and recognize innova..., Veridiam was one of nine winners, selected fro...red at the recent awards ceremony. San Diego-based...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...he Ninth Circuit Court of Appeals reversed a U.S. ...allowed to pursue all of its claims against The La...urt for trial. CTI filed a complaint against The ... consultant for CTI,s product TRISENOX, in 2007 se...
(Date:11/19/2009)...Newswire/ -- Danish Prince Joachim inaugurated the...in Kalundborg, Denmark, on Wednesday, November 18....est 2nd generation ethanol demonstration biorefine...he plant,s innovative process for converting straw... first to market with commercial enzymes for conve...
(Date:11/19/2009)...ewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: N...ng letter to its shareholders, discussing the Comp...iopharmaceuticals Holdings, Inc. (CHBP), an integr...e,s Republic of China. The merger gives NeoStem a ...ical Co. Ltd., CHBP,s primary operating subsidiary...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
...M CONTINUES ITS EXPANSION INTO EUROPE AND STRENGTH...LE, Fla., May 12 OmniComm Systems, Inc. (OTC Bull...ronic data capture (EDC) solutions for clinical tr... European presence and management team with the ad...esident, Europe & Asia/Pacific based in OmniCo...
... Stock Exchange Symbol: MS , , EDMONTON, May 11 /...MS), a leading developer in the treatment of multi...operational results for the first quarter, ended M... results from MAESTRO-01, the first of our two piv... secondary progressive multiple sclerosis, in the ...
...RT, Mich., May 11 The following is being released...shareholders: , , As the founding CEO of Amylin a...to know how I plan to vote at our annual meeting. ... has created one of the best product and technolog..., shareholders have suffered because sales results...
Other Biology Technology:OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific 2OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific 3BioMS Medical Announces First quarter 2009 results 2BioMS Medical Announces First quarter 2009 results 3BioMS Medical Announces First quarter 2009 results 4BioMS Medical Announces First quarter 2009 results 5BioMS Medical Announces First quarter 2009 results 6BioMS Medical Announces First quarter 2009 results 7BioMS Medical Announces First quarter 2009 results 8BioMS Medical Announces First quarter 2009 results 9
...Compatible with AutoGen AutoGenesys, BioRobotics B...automated colony picking systems This CLS number i...rnings product number. If showing no availability ...er (D9314) or contact customer service for assista...
Corning C ulture Dishes, 150X25 mm, Tc-Treated, PS, Sterile from Sigma-Aldrich
...scent Detection System is intended for use in the ...by an in-house validated method for in vitro nucle...rest. • The XpressPack Luminescent Detect...ed to detect amplified nucleic acid specific to th...
...Dish uses include large-scale colony-counting and ... Compatible with PBA Flexys TM automated colony p...w product number, created to easily match Cornings...lease order under the old Sigma-Aldrich number (Z3...
Biology Products: